REQUEST A DEMO
Total
USD $0.00
Search more companies

Aura Life Sciences Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Aura Life Sciences Private Limited Profile Updated: March 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Aura Life Sciences Private Limited is a company based in India, with its head office in Mumbai. It operates in the Pharmaceutical and Medicine Manufacturing sector. Aura Life Sciences Private Limited was incorporated on November 19, 2004. From the latest financial highlights, Aura Life Sciences Private Limited reported a net sales revenue increase of 26.73% in 2024. Its total assets grew by 8.48% over the same period. In, 2024, the company’s net profit margin increased by 0.09%.

Legal Address
Flat No 4 Jeevan Adhar Co Ophsg Soc Mahant Road Vile Parle East
Mumbai; Maharashtra; Postal Code: 400057

Contact Details: Purchase the Aura Life Sciences Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Aura Life Sciences Private Limited report to view the information.
Financial Auditors:
Purchase the Aura Life Sciences Private Limited report to view the information.
Incorporation Date:
November 19, 2004
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Aura Life Sciences Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
26.73%
Total Operating Revenue
26.72%
Operating Profit
28.81%
EBITDA
27.35%
Net Profit/Loss for the Period
41.72%
Total Assets
8.48%
Total Equity
8.48%
Operating Profit Margin
0.04%
Net Profit Margin
0.09%
Return on Equity (ROE)
1.84%
Debt / Equity
-19%
Quick Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?